Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00003308What this trial is testingRadiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+2 more Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00043407What this trial is testingCPG 7909 in Patients Wih Stage IV Renal Cell CancerWho this might be right forCarcinoma, Renal Cell Pfizer 42
Testing effectiveness (Phase 2)Ended earlyNCT00704938What this trial is testingGene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerWho this might be right forKidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 3
Large-scale testing (Phase 3)Study completedNCT00002737What this trial is testingInterferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC 320
Early research (Phase 1)Ended earlyNCT00623077What this trial is testingMT2004-30: Tomotherapy for Solid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more Masonic Cancer Center, University of Minnesota 23
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Testing effectiveness (Phase 2)Study completedNCT00003091What this trial is testingHigh-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaWho this might be right forKidney CancerMelanoma (Skin) Hoag Memorial Hospital Presbyterian 40
Not applicableStudy completedNCT00617799What this trial is testingBiomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaWho this might be right forKidney CancerMelanoma (Skin) University of Nebraska 15
Testing effectiveness (Phase 2)Study completedNCT01835158What this trial is testingCabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 157
Early research (Phase 1)UnknownNCT00016042What this trial is testingFluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal CancerWho this might be right forColorectal CancerKidney Cancer St. Luke's Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03092856What this trial is testingAxitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+1 more University of Southern California 62
Testing effectiveness (Phase 2)Study completedNCT00039429What this trial is testingAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 180
Early research (Phase 1)Study completedNCT01061411What this trial is testingDalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more Roswell Park Cancer Institute 16
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00085436What this trial is testingDC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCCWho this might be right forKidney Cancer Dartmouth-Hitchcock Medical Center 18
Testing effectiveness (Phase 2)Ended earlyNCT03274258What this trial is testingPhase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary CarcinomaWho this might be right forKidney Medullary CarcinomaLoss of INI 1 Protein ExpressionStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 10
Not applicableStudy completedNCT01892930What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing SurgeryWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02599779What this trial is testingA Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC PatientsWho this might be right forStage IV Renal Cell Cancer AJCC V7 Sunnybrook Health Sciences Centre 4
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center